BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15126816)

  • 1. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.
    Hill B; Belville W; Bruskewitz R; Issa M; Perez-Marrero R; Roehrborn C; Terris M; Naslund M
    J Urol; 2004 Jun; 171(6 Pt 1):2336-40. PubMed ID: 15126816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months.
    Cimentepe E; Unsal A; Saglam R
    J Endourol; 2003 Mar; 17(2):103-7. PubMed ID: 12689404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.
    Schatzl G; Madersbacher S; Djavan B; Lang T; Marberger M
    Eur Urol; 2000 Jun; 37(6):695-701. PubMed ID: 10828670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia.
    Law YXT; Chen WJK; Shen L; Chua WJ
    Investig Clin Urol; 2019 Sep; 60(5):351-358. PubMed ID: 31501797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers.
    Zlotta AR; Giannakopoulos X; Maehlum O; Ostrem T; Schulman CC
    Eur Urol; 2003 Jul; 44(1):89-93. PubMed ID: 12814680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection.
    Hammadeh MY; Madaan S; Hines J; Philp T
    Urology; 2003 Jun; 61(6):1166-71. PubMed ID: 12809891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
    Otaola-Arca H; Álvarez-Ardura M; Molina-Escudero R; Fernández MI; Páez-Borda Á
    Int Braz J Urol; 2021; 47(1):131-144. PubMed ID: 33047918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral needle ablation Prostiva for treating symptomatic benign prostatic hyperplasia: a review].
    Xylinas E; Le Gal S; Descazeaud A
    Prog Urol; 2010 Sep; 20(8):566-71. PubMed ID: 20832033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.